- Home
- AUPH vs PGY Comparison
AUPH vs PGY Comparison
Compare AUPH & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | PGY |
|---|---|---|
| Founded | 1993 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.0B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUPH | PGY |
|---|---|---|
| Price | $14.80 | $11.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $17.25 | ★ $34.50 |
| AVG Volume (30 Days) | 883.5K | ★ 3.7M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.35 | $14.27 |
| Revenue Next Year | $15.66 | $14.19 |
| P/E Ratio | ★ $7.14 | $13.54 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $6.83 | $8.50 |
| 52 Week High | $16.54 | $44.99 |
Technical Indicators
Market Signals| Indicator | AUPH | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 35.32 |
| Support Level | $14.56 | $10.51 |
| Resistance Level | $15.23 | $25.47 |
| Average True Range (ATR) | 0.56 | 0.66 |
| MACD | 0.06 | 0.35 |
| Stochastic Oscillator | 74.42 | 45.33 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.